Agios Pharmaceuticals, Inc. (AGIO) Financial Analysis & Valuation | Quarter Chart

Agios Pharmaceuticals, Inc. (AGIO)

AGIO
Price: $42.79
Fair Value: 🔒
🔒score
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzym... more
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development o... more
Description Shares
Market Cap$2.54BExchangeNASDAQ
SectorHealthcareIndustryBiotechnology
CountryUSCEOBrian Goff
IPO Date2013-07-24CAGR0.07%
Employees486Websitewww.agios.com
Div. YieldPayout Ratio
Buy Back YieldTotal Yield
AGIO chart loading...
Fundamentals Technicals
Enterprise Value$2.77BP/E Ratio-5.9
Forward P/E-9.33PEG Ratio
P/S Ratio670.65P/B Ratio39.15
P/CF Ratio-115.06P/FCF Ratio-115.06
EPS$-7.25EPS Growth 1Y
EPS Growth 3YEPS Growth 5Y
Revenue Growth 1Y78.34%Gross Margin0.82%
Operating Margin-7.2%Profit Margin-6.4%
ROE-0.34%ROA-0.36%
ROCE-0.42%Current Ratio14.19
Quick Ratio13.59Cash Ratio1.93
Debt/Equity0.03Interest Coverage
Altman Z Score18.76Piotroski Score3